Acrivon Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:ACRV) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -30.12 M-42.64 M-65.67 M-63.66 M -64.67 M Cash from investing activities -141.68 M50.72 M-51.77 M66.1 M 60.01 M Cash from financing activities 101.71 M-1.55 M121.03 M-749 K -439 K Free cash flow -30.12 M-42.64 M-65.67 M-65.33 M -66.29 M

News

Acrivon Therapeutics, Inc. (ACRV) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow (NASDAQ:ACRV) 2026-03-04

Acrivon Therapeutics, Inc. (ACRV) Upgraded to Buy: Here's Why

Jefferies reiterates Acrivon Therapeutics stock rating on trial data

Acrivon to present ACR-368 endometrial cancer data at ESGO congress

Sunday’s Insider Activity: Top Executives Make Strategic Moves

Acrivon Therapeutics CEO Blume-Jensen buys $82k in shares

Acrivon Therapeutics COO Devroe buys $17k in shares

Piper Sandler raises Acrivon Therapeutics stock price target to $8 on positive cancer data

Acrivon Therapeutics stock plunges after mixed cancer trial results

Why Is Acrivon Therapeutics Stock Falling Today? - Acrivon Therapeutics (NASDAQ:ACRV)

Acrivon reports 52% response rate in serous endometrial cancer trial

Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Acrivon Therapeutics (NASDAQ:ACRV), Cormedix (NASDAQ:CRMD)